Kathrin Geiger

6.2k total citations · 1 hit paper
137 papers, 4.9k citations indexed

About

Kathrin Geiger is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Kathrin Geiger has authored 137 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 22 papers in Genetics and 22 papers in Epidemiology. Recurrent topics in Kathrin Geiger's work include Glioma Diagnosis and Treatment (15 papers), Spectroscopy Techniques in Biomedical and Chemical Research (15 papers) and Spectroscopy and Chemometric Analyses (10 papers). Kathrin Geiger is often cited by papers focused on Glioma Diagnosis and Treatment (15 papers), Spectroscopy Techniques in Biomedical and Chemical Research (15 papers) and Spectroscopy and Chemometric Analyses (10 papers). Kathrin Geiger collaborates with scholars based in Germany, Austria and United States. Kathrin Geiger's co-authors include Kai Simons, Lawrence Rajendran, Heinz Drexel, Christoph H. Saely, Tobias Zahn, Paul Verkade, Patrick Keller, Masanori Honsho, Gabriele Schackert and Matthias Kirsch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Kathrin Geiger

128 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alzheimer's disease β-amyloid peptides are released in association with exosomes

2006 1.1k citations Lawrence Rajendran, Masanori Honsho et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Kathrin Geiger

Since Specialization

Citations

This map shows the geographic impact of Kathrin Geiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Geiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Geiger more than expected).

Fields of papers citing papers by Kathrin Geiger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Geiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Geiger. The network helps show where Kathrin Geiger may publish in the future.

Co-authorship network of co-authors of Kathrin Geiger

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Geiger. A scholar is included among the top collaborators of Kathrin Geiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Geiger. Kathrin Geiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients 2023 ·Journal of Cancer Research and Clinical Oncology ·Axel Muendlein, Kathrin Geiger, Christine Heinzle, (unknown), Thomas Winder, (unknown), (unknown), Eva Maria Brandtner, Andreas Leiherer, Heinz Drexel, Thomas Decker, (unknown), Tobias Dechow	5
2	SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study 2022 ·BMJ Open ·(unknown), Axel Muendlein, Thomas Winder, Peter Fraunberger, (unknown), Kathrin Geiger, Miriam Klausberger, Mark Duerkop, (unknown), Beatrix Mutschlechner, (unknown), Magdalena Benda, (unknown), (unknown), Heinz Drexel, Aloïs B. Lang, Andreas Leiherer	2
3	Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors 2022 ·Oncology Research and Treatment ·Thomas Decker, (unknown), (unknown), Gerhard W. Fischer, Kathrin Geiger, (unknown), (unknown), Tobias Dechow, Axel Muendlein	3
4	CORRELATION BETWEEN CIRCULATING MICRORNAS AND CHRONIC KIDNEY DISEASE IN PATIENTS WITH AND WITHOUT TYPE 2 DIABETES 2018 ·Journal of the American College of Cardiology ·Axel Muendlein, Kathrin Geiger, Andreas Leiherer, Christoph H. Saely, (unknown), (unknown), (unknown), Alexander Vonbank, Peter Fraunberger, Heinz Drexel	1
5	Optical Analysis of Glioma: Fourier-Transform Infrared Spectroscopy Reveals the IDH1 Mutation Status 2017 ·Clinical Cancer Research ·Ortrud Uckermann, Tareq A. Juratli, Roberta Galli, Marina Clemente Conde, Ralf Wiedemuth, Dietmar Krex, Kathrin Geiger, Achim Temme, Gabriele Schackert, Edmund Koch, Gerald Steiner, Matthias Kirsch	27
6	Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients 2015 ·Journal of Neuro-Oncology ·Tareq A. Juratli, (unknown), Kathrin Geiger, Thomas Pinzer, Mechthild Krause, Gabriele Schackert, Dietmar Krex	12
7	Label-Free Delineation of Brain Tumors by Coherent Anti-Stokes Raman Scattering Microscopy in an Orthotopic Mouse Model and Human Glioblastoma 2014 ·PLoS ONE ·Ortrud Uckermann, Roberta Galli, (unknown), Elke Leipnitz, Kathrin Geiger, Gabriele Schackert, Edmund Koch, Gerald Steiner, Matthias Kirsch	70
8	The Ventral Midline Thalamus (Reuniens and Rhomboid Nuclei) Contributes to the Persistence of Spatial Memory in Rats 2012 ·Journal of Neuroscience ·Michaël Loureiro, Thibault Cholvin, Joëlle Lopez, Nicolas Mérienne, (unknown), Brigitte Cosquer, Kathrin Geiger, Christian Kelche, Jean‐Christophe Cassel, Anne Pereira de Vasconcelos	108
9	Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAF 2011 ·Journal of Molecular Diagnostics ·Alois Lang, Heinz Drexel, (unknown), Nicole Stark, Thomas Winder, Kathrin Geiger, Axel Muendlein	90
10	Giant Cell Glioblastoma Is Associated With Altered Aurora B Expression and Concomitant p53 Mutation 2010 ·Journal of Neuropathology & Experimental Neurology ·Achim Temme, Kathrin Geiger, Ralf Wiedemuth, (unknown), (unknown), Torsten Pietsch, Jörg Felsberg, Guido Reifenberger, Masaaki Tatsuka, Christian Hagel, Manfred Westphal, Hilmar Berger, Matthias Simon, Michael Weller, Gabriele Schackert	24
11	Carnosine retards tumor growth in vivo in an NIH3T3-HER2/neu mouse model 2010 ·Molecular Cancer ·Christof Renner, (unknown), Beate Fuchs, Kathrin Geiger, Matthias Hermes, Jan G. Hengstler, Rolf Gebhardt, Jürgen Meixensberger, Frank Gaunitz	78
12	The Anti-apoptotic Protein BCL2L1/Bcl-xL Is Neutralized by Pro-apoptotic PMAIP1/Noxa in Neuroblastoma, Thereby Determining Bortezomib Sensitivity Independent of Prosurvival MCL1 Expression 2010 ·Journal of Biological Chemistry ·Judith Hagenbuchner, Michael J. Ausserlechner, (unknown), (unknown), Bernhard Meister, Martin Bodner, Andreas Villunger, Kathrin Geiger, Petra Obexer	66
13	Increased Advanced Glycation End-Products (AGEs) in Trabecular Meshwork of Patients With Primary and Secondary Glaucoma 2008 ·Investigative Ophthalmology & Visual Science ·(unknown), Eberhard Spoerl, Andreas Boehm, Kathrin Geiger, Lutz E. Pillunat	1
14	Increased Aβ Production Leads to Intracellular Accumulation of Aβ in Flotillin-1-Positive Endosomes 2007 ·Neurodegenerative Diseases ·Lawrence Rajendran, Marlen Knobloch, Kathrin Geiger, (unknown), Roger M. Nitsch, Kai Simons, Uwe Konietzko	40
15	Alzheimer's disease β-amyloid peptides are released in association with exosomes breakdown → 2006 ·Proceedings of the National Academy of Sciences ·Lawrence Rajendran, Masanori Honsho, Tobias Zahn, Patrick Keller, Kathrin Geiger, Paul Verkade, Kai Simons	1067
16	Ezrin Immunoreactivity Reveals Specific Astrocyte Activation in Cerebral HIV 2006 ·Journal of Neuropathology & Experimental Neurology ·Kathrin Geiger, (unknown), W. Schlote, Amin Derouiche	11
17	Experimental treatment of stroke in spontaneously hypertensive rats by CD34+ and CD34- cord blood cells 2005 ·SHILAP Revista de lepidopterología ·Dietmar Egger, Christian Bührle, Albrecht Günther, (unknown), Kathrin Geiger, Ina Kowalski, Johannes Boltze, Manja Kamprad, Frank Emmrich	8
18	Transthyretin and transferrin in hemangioblastoma stromal cells 2000 ·Pathology - Research and Practice ·(unknown), Kathrin Geiger, Franz König, (unknown), W. Schlote	14
19	CD5-positive B cells in healthy elderly humans are a polyclonal B cell population 2000 ·European Journal of Immunology ·Kathrin Geiger, Ulf Klein, Andreas Bräuninger, Stefan Berger, Korinna Leder, Klaus Rajewsky, Martin‐Leo Hansmann, Ralf Küppers	22
20	Experimentelle Untersuchungen zum Säure-Basen-Haushalt und Laktatmetabolismus der Leber 1995 ·AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie ·Gabriele Nöldge‐Schomburg, (unknown), Kathrin Geiger, R. Zander	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact